Cargando…
Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study
BACKGROUND: In patients with resectable colorectal liver metastases (CRLM), the role of pre- and postoperative systemic therapy continues to be debated. Previous studies have shown that circulating tumor DNA (ctDNA) analysis, as a marker of minimal residual disease, is a powerful prognostic factor i...
Autores principales: | Tie, Jeanne, Wang, Yuxuan, Cohen, Joshua, Li, Lu, Hong, Wei, Christie, Michael, Wong, Hui Li, Kosmider, Suzanne, Wong, Rachel, Thomson, Benjamin, Choi, Julian, Fox, Adrian, Field, Kathryn, Burge, Matthew, Shannon, Jenny, Kotasek, Dusan, Tebbutt, Niall C., Karapetis, Christos, Underhill, Craig, Haydon, Andrew, Schaeffer, Joy, Ptak, Janine, Tomasetti, Cristian, Papadopoulos, Nicholas, Kinzler, Kenneth W., Vogelstein, Bert, Gibbs, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128260/ https://www.ncbi.nlm.nih.gov/pubmed/33939694 http://dx.doi.org/10.1371/journal.pmed.1003620 |
Ejemplares similares
-
FAST-SeqS: A Simple and Efficient Method for the Detection of Aneuploidy by Massively Parallel Sequencing
por: Kinde, Isaac, et al.
Publicado: (2012) -
On the slope of the regression between stem cell divisions and cancer risk, and the lack of correlation between stem cell divisions and environmental factors-associated cancer risk
por: Tomasetti, Cristian, et al.
Publicado: (2017) -
An isogenic cell line panel for sequence-based screening of targeted anticancer drugs
por: Cook, Ashley L., et al.
Publicado: (2022) -
Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients
por: Bae, Susie, et al.
Publicado: (2015) -
An Australian translational Study to evaluate the prognostic role of inflammatory markers in patients with metastatic ColorEctal caNcer Treated with bevacizumab (Avastin™) [ASCENT]
por: Clarke, Stephen, et al.
Publicado: (2013)